Trial Profile
A 12-month study to evaluate the effects of atorvastatin on serum high-sensitive C-reactive protein and total cholesterol levels in Chinese patients with atrial fibrillation.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Nov 2015
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Amiodarone
- Indications Atrial fibrillation
- Focus Pharmacodynamics; Therapeutic Use
- 29 Nov 2015 New trial record
- 11 Nov 2015 Results published in the American Journal of Therapeutics